Health & Bio

Novo's Wegovy pill outpaces Lilly's Foundayo in early U.S. rollout

Four months in, oral Wegovy sees tens of thousands of prescriptions via telehealth. Lilly's Foundayo struggles with brand awareness and penetration stateside.

Primary sources · 2
Related storylines
← View the full 2026-05-18 (Mon) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →